Suchergebnisse - "Gambardella, V"

PubPharm (9)

1

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer : outcomes and biomarker analysis from the SUMMIT trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Jhaveri, K. | Eli, L. | Wildiers, H. | +39

2

In the literature : July 2022

enthalten in: ESMO open | 2022

von Gambardella, V. | Martinelli, E. | Tarazona, N. | +1

3

In the literature : April 2022

enthalten in: ESMO open | 2022

von Ciardiello, D. | Roda, D. | Gambardella, V. | +1

4

In the literature : February 2022

enthalten in: ESMO open | 2022

von Gambardella, V. | Cejalvo, J. | González-Barrallo, I. | +2

5

Reply to the letter to the editor : adjuvant nivolumab for the management of the pathological residual disease in esophageal or junctional tumors: a word of caution by P.K. Garg, R. Kumar and P. Dixit

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Smyth, E. | Gambardella, V. | Cervantes, A. | +1

CommentOn: Ann Oncol. 2021 May;32(5):590-599. - PMID 33609722

6

Checkpoint inhibitors for gastroesophageal cancers : dissecting heterogeneity to better understand their role in first-line and adjuvant therapy

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Smyth, E. | Gambardella, V. | Cervantes, A. | +1

CommentIn: Ann Oncol. 2021 Sep;32(9):1189-1190. - PMID 33957223

7

EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness

enthalten in: Scientific reports | 2020

von Gimeno-Valiente, F. | Riffo-Campos, �. | Ayala, G. | +12

8

Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Tarazona, N. | Gimeno-Valiente, F. | Gambardella, V. | +17

9

Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Gambardella, V. | Fleitas, T. | Tarazona, N. | +8

1
[1]